News Release: 2015

BioMark AGM

BioMark is holding its Annual General and Special Meeting on September 17, 2015 at 925 W Georgia Street #1820, Vancouver, BC. We look forward to seeing you at the meeting. For more information, please visit SEDAR

DOWNLOAD AGM MATERIALS

FORM OF PROXY (PDF)

NOTICE OF MEETING (PDF)

MANAGEMENT INFORMATION CIRCULAR (PDF)

BioMark Diagnostics to Conduct Validation Studies for its Patented Assays in Patients with Lung Cancer

Dr. James Bond of Surrey Memorial Hospital to act as Principal Investigator

BioMark Diagnostics to Conduct Validation Studies (PDF)

 

———————————————

BioMark Diagnostics to Conduct Validation Studies for its Patented Assays in Patients with Lung Cancer

Dr. James Bond of Surrey Memorial Hospital to act as Principal Investigator

BioMark Diagnostics to Conduct Validation Studies (PDF)

 

———————————————

BioMark Diagnostics Receives Clearance from Health Canada to Commence Clinical Trial with Patented Non-Invasive, Urine-Based Assay to Measure Response to Treatment for Lung Cancer

Sept 9thBioMark Diagnostics Receives Clearance from Health Canada (PDF)

 

———————————————